Abstracts tagged "pediatrics and interdisciplinary rheumatology team"

Abstract Number: 2868 • 2019 ACR/ARP Annual Meeting
Baseline Clinical and Serological Findings in Pediatric-Onset Discoid Lupus Erythematosus: Analysis of a Multicenter Retrospective Cohort Study
Nnenna Ezeh¹, Kevin Buhr², Cordellia Nguyen³, Ohoud Al Ahmed⁴, Stacy Ardoin⁵, Virginia Barton⁶, Samantha Bell⁷, Heather Brandling-Bennett⁸, Leslie Castelo-Soccio⁹, Yvonne Chiu¹⁰, Benjamin Chong¹¹, Dominic Co¹², Irene Lara-Corrales¹³, Amber Cintosun¹³, Lucia Diaz¹⁴, Scott Andrew Elman¹⁵, Esteban Fernandez Faith⁴, Maria Teresa Garcia-Romero¹⁶, Julie Grossman-Kranseler⁸, Aimee Hersh¹⁷, Marcia Hogeling¹⁸, Andrew Hudson¹⁹, Raegan Hunt²⁰, Erin Ibler¹⁰, Mariana Marques²¹, Reesa Monir²², Vikash Oza²³, Amy Paller²⁴, Elana Putterman⁹, Pamela Rodriguez-Salgado¹⁶, Jennifer Schoch²², Allison Truong¹⁸, Jason Wang²³, Lara Wine Lee⁶, Ruth Ann Vleugels¹⁵, Marisa Klein-Gitelman²⁵, Emily von-Scheven²⁶, Victoria Werth²⁷, Kaveh Ardalan²⁸and Lisa Arkin²⁹,¹University of Wisconsin School of Medicine and Public Health, Madison, WI,²Department of Biostatistics & Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison,³University of Wisconsin School of Medicine and Public Health, Madison,⁴Department of Pediatrics, Division of Dermatology, Nationwide Children's Hospital/Ohio State University, Columbus,⁵Nationwide Children's Hospital, Columbus, OH,⁶Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston,⁷Department of Pediatrics, Division of Rheumatology, University of California at San Francisco, San Francisco,⁸Division of Dermatology; Department of Pediatrics, Seattle Children's Hospital/University of Washington School of Medicine, Seattle,⁹Department of Pediatrics, Section of Dermatology, Children's Hospital of Philadelphia, Philadelphia,¹⁰Departments of Dermatology and Pediatrics, Medical College of Wisconsin, Milwaukee,¹¹University of Texas Southwestern, Dallas,¹²Department of Pediatrics, Division of Rheumatology, University of Wisconsin School of Medicine and Public Health, Madison,¹³Department of Pediatrics, Division of Dermatology, The Hospital for Sick Children/University of Toronto, Toronto, Canada,¹⁴Department of Pediatrics, Division of Dermatology, Dell Medical School/Dell Children's Hospital, Austin, Texas,¹⁵Department of Dermatology, Boston's Children Hospital/Harvard Medical School, Boston,¹⁶Department of Dermatology, National Institute for Pediatrics, Mexico City, Mexico,¹⁷University of Utah, Salt Lake City, UT,¹⁸Department of Dermatology, University of California at Los Angeles, Los Angeles,¹⁹Department of Dermatology, University of Texas Southwestern Medical Center, Dallas,²⁰Departments of Pediatrics and Dermatology, Texas Children's Hospital, Houston, Texas,²¹Division of Rheumatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago,²²Department of Dermatology, University of Florida School of Medicine, Gainesville,²³Departments of Pediatrics and Dermatology, New York University School of Medicine, New York,²⁴Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine/Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago,²⁵Department of Pediatrics, Division of Rheumatology, Northwestern University Feinberg School of Medicine/Ann & Robert H. Lurie Children's Hospital, Chicago,²⁶University of California San Francisco, San Francisco,²⁷Corporal Michael J. Crescenz VAMC, Philadelphia, PA, USA and Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA,²⁸Division of Pediatric Rheumatology, Department of Pediatrics, Northwestern University, Chicago, Illinois,²⁹Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
Background/Purpose: DLE is a rare, disfiguring disorder in children. Small retrospective studies suggest 20-25% of patients progress to SLE. Progression risk factors are poorly understood,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].